Physician profile
Brian A Perez
NPI 1598254443
$53,266.28
in general payments reported to CMS, 2019-2025
8 companies · $1,887 in 2025
The $1,887 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,469 · 2023: $25K · 2024: $25K · 2025: $1,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Grant: $24K · Food and Beverage: $3,318 · Travel and Lodging: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $23,827.24 |
| Grant | $23,750.00 |
| Food and Beverage | $3,317.73 |
| Travel and Lodging | $902.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $47,758.18 | 2023-2024 | Evos, Journey II, Real Intelligence |
| Stryker Corporation | $2,122.58 | 2022-2025 | Mako, Variax, Pangea |
| Zimmer Biomet Holdings, INC. | $1,544.97 | 2024-2025 | Oxford, Persona, Rosa |
| Paladin Technology Solutions | $1,200.00 | 2022 | |
| Kerecis Limited | $242.42 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Davol INC. | $191.46 | 2024-2025 | Channel Drain |
| Intellijoint Surgical INC. | $138.78 | 2024 | Intellijoint Hip |
| Seapearl East, INC | $67.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.